Vitaplant

Vitaplant is a Swiss biotechnology company specializing in the development and cultivation of high-quality medicinal plants for the pharmaceutical, nutraceutical, and cosmetic industries. The company utilizes advanced plant breeding, in vitro culture, and analytical techniques to ensure standardized active ingredient profiles in its botanical raw materials. Vitaplant provides comprehensive services ranging from seed selection and cultivation optimization to the production of specialized plant extracts under GMP conditions. Since its acquisition by Max Zeller Söhne AG, it has served as a critical research and production hub for high-quality phytopharmaceuticals. The company is globally recognized for its expertise in domesticating wild plants to create sustainable and reliable supply chains for the life sciences sector.